Loading clinical trials...
Loading clinical trials...
Screening, Evaluation, and Assessment (SEA) Protocol at the NIDA IRP
Conditions
Locations
1
United States
National Institute on Drug Abuse
Baltimore, Maryland, United States
Start Date
September 4, 2024
Primary Completion Date
January 1, 2045
Completion Date
January 1, 2047
Last Updated
April 8, 2026
NCT06790641
NCT07027839
NCT06413979
NCT07279558
NCT05492825
NCT07341230
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions